|
FDA Warning Letter Cites Canadian Drugmaker for Vendor Qualification Lapses
The FDA has hit International Laboratories Canada with a warning letter for good manufacturing practice (GMP) violations related to supplier qualification and the company’s quality control unit.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives